compounding glp-1 enforcement news Compound versions of drugs for weight loss halted by FDA What Are Compounded GLP-1 Medications?

Weight Loss and Slowing Growth Rate in Pediatric Patients with ADHD In a controlled trial of VYVANSE in pediatric patients ages 6 to 12 years (Study 1), mean weight loss from baseline after 4 weeks of therapy was -0.9, -1.9, and -2.5 pounds, respectively, for patients receiving 30 mg, 50 mg, and 70 mg of VYVANSE, compared to a 1 pound weight gain for patients receiving placebo

While compounded medications are produced in licensed facilities and regulated by state Boards of Pharmacy, they have not been evaluated by the FDA for safety, quality, or efficacy

Proactively drinking fluids helps you stay ahead of dehydration

Its now available on-demand so you can access the full program whenever it fits your schedule

471,472 It was approved by the FDA in March 2022 for moderate to severely active UC at a dose of 45 mg per day for 8 weeks and then 15 or 30 mg per day for maintenance treatment